Benjamin Prescott

4.5k total citations
125 papers, 3.7k citations indexed

About

Benjamin Prescott is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Benjamin Prescott has authored 125 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Immunology, 38 papers in Epidemiology and 32 papers in Molecular Biology. Recurrent topics in Benjamin Prescott's work include Pneumonia and Respiratory Infections (32 papers), Immunodeficiency and Autoimmune Disorders (32 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Benjamin Prescott is often cited by papers focused on Pneumonia and Respiratory Infections (32 papers), Immunodeficiency and Autoimmune Disorders (32 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Benjamin Prescott collaborates with scholars based in United States, Australia and Lebanon. Benjamin Prescott's co-authors include Philip W. Stashak, Diana F. Amsbaugh, Phillip J. Baker, Robert M. Chanock, G. Caldes, Phillip J. Baker, O Sobĕslavský, Rolf F. Barth, Carl T. Hansen and Gladys Kauffmann and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Benjamin Prescott

122 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Prescott United States 36 1.9k 1.1k 757 630 620 125 3.7k
Örjan Ouchterlony Sweden 17 1.5k 0.8× 738 0.7× 2.0k 2.6× 688 1.1× 222 0.4× 56 5.9k
Edward A. Havell United States 33 2.3k 1.2× 1.1k 1.0× 1.1k 1.5× 417 0.7× 189 0.3× 74 4.6k
John H. Schwab United States 38 1.4k 0.7× 728 0.7× 1.1k 1.4× 239 0.4× 402 0.6× 104 4.2k
Christina Cheers Australia 38 3.0k 1.6× 988 0.9× 779 1.0× 387 0.6× 230 0.4× 101 5.0k
A. C. Wardlaw United Kingdom 26 894 0.5× 443 0.4× 855 1.1× 254 0.4× 749 1.2× 102 3.1k
Aldo Tagliabue Italy 36 2.3k 1.2× 487 0.5× 885 1.2× 287 0.5× 345 0.6× 131 3.9k
Peter F. Mühlradt Germany 36 4.0k 2.1× 1.1k 1.0× 1.7k 2.3× 178 0.3× 1.2k 2.0× 97 6.1k
G Biozzi France 29 1.3k 0.7× 445 0.4× 720 1.0× 353 0.6× 194 0.3× 169 3.5k
J. H. L. Playfair United Kingdom 45 2.7k 1.4× 800 0.7× 812 1.1× 565 0.9× 115 0.2× 171 5.9k
Chao-Ming Tsai United States 17 780 0.4× 530 0.5× 1.3k 1.7× 236 0.4× 854 1.4× 34 3.6k

Countries citing papers authored by Benjamin Prescott

Since Specialization
Citations

This map shows the geographic impact of Benjamin Prescott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Prescott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Prescott more than expected).

Fields of papers citing papers by Benjamin Prescott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Prescott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Prescott. The network helps show where Benjamin Prescott may publish in the future.

Co-authorship network of co-authors of Benjamin Prescott

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Prescott. A scholar is included among the top collaborators of Benjamin Prescott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Prescott. Benjamin Prescott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baker, Phillip J., et al.. (1988). Examination of the Differential Characteristics of Amplifier and Contrasuppressor T Cells. Immunobiology. 177(4-5). 438–448. 9 indexed citations
2.
Domer, Judith E., Philip W. Stashak, Karen L. Elkins, et al.. (1986). Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive components. Cellular Immunology. 101(2). 403–414. 38 indexed citations
3.
Taylor, Christopher E., Philip W. Stashak, G. Caldes, et al.. (1983). Activation of antigen-specific suppressor T cells by B cells from mice immunized with type III pneumococcal polysaccharide.. The Journal of Experimental Medicine. 158(3). 703–717. 58 indexed citations
4.
Hinshaw, Virginia S., Gillian M. Air, Adrian J. Gibbs, et al.. (1982). Antigenic and genetic characterization of a novel hemagglutinin subtype of influenza A viruses from gulls. Journal of Virology. 42(3). 865–872. 111 indexed citations
5.
Baker, Philip J., Diana F. Amsbaugh, Philip W. Stashak, G. Caldes, & Benjamin Prescott. (1982). Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide.. The Journal of Immunology. 128(3). 1059–1062. 52 indexed citations
6.
Markham, Richard B., Philip W. Stashak, Benjamin Prescott, Diana F. Amsbaugh, & Phillip J. Baker. (1977). Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide I. Comparison of the suppression induced by con A and low dose paralysis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 118(3). 952–6. 17 indexed citations
7.
Brünner, Helmut, Benjamin Prescott, Harry B. Greenberg, et al.. (1977). Unexpectedly High Frequency of Antibody to Mycoplasma pneumoniae in Human Sera as Measured by Sensitive Techniques. The Journal of Infectious Diseases. 135(4). 524–530. 47 indexed citations
8.
Markham, Richard B., Norman D. Reed, Philip W. Stashak, et al.. (1977). Effect of concanavalin a on lymphocyte interactions involved in the antibody response to type iii pneumococcal polysaccharide. II. Ability of suppressor t cells to act on both b cells and amplifier t cells to limit the magnitude of the antibody response.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 119(3). 1163–1168. 35 indexed citations
9.
Jones, Jeffrey M., Diana F. Amsbaugh, & Benjamin Prescott. (1976). Kinetics of the antibody response to type III pneumococcal polysaccharide (SSS-III). I. Use of 125I-labeled SSS-III to study serum antibody levels, as well as the distribution and excretion of antigen after immunization.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 116(1). 41–51. 29 indexed citations
10.
Morse, Herbert C., Benjamin Prescott, Sue S. Cross, Philip W. Stashak, & Phillip J. Baker. (1976). Regulation of the antibody response to type III pneumococcal polysaccharide. V. Ontogeny of factors influencing the magnitude of the plaque-forming cell response.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 116(2). 279–87. 49 indexed citations
11.
Jones, Jeffrey M., Diana F. Amsbaugh, & Benjamin Prescott. (1976). Kinetics of the antibody response to type III pneumococcal polysaccharide. II. Factors influencing the serum antibody levels after immunization with an optimally immunogenic dose of antigen.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 116(1). 52–64. 40 indexed citations
12.
Jones, Jeffrey M., Diana F. Amsbaugh, & Benjamin Prescott. (1976). Kinetics of the Antibody Response to Type III Pneumococcal Polysaccharide. The Journal of Immunology. 116(1). 52–64. 25 indexed citations
13.
Baker, Phillip J., Philip W. Stashak, Diana F. Amsbaugh, & Benjamin Prescott. (1974). Regulation of the Antibody Response to Type III Pneumococcal Polysaccharide. The Journal of Immunology. 112(1). 404–409. 35 indexed citations
14.
Baker, Phillip J., Norman D. Reed, Philip W. Stashak, Diana F. Amsbaugh, & Benjamin Prescott. (1973). REGULATION OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE. The Journal of Experimental Medicine. 137(6). 1431–1441. 129 indexed citations
15.
Prescott, Benjamin. (1972). Antitumor activity of 2,2-hydrazobis(3-chloro-1,4-naphthoquinone) against Walker 256 (intramuscular) carcinosarcoma. Journal of Medicinal Chemistry. 15(1). 107–107. 2 indexed citations
16.
Baker, Phillip J., Philip W. Stashak, Diana F. Amsbaugh, & Benjamin Prescott. (1971). Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.. PubMed. 20(4). 469–80. 134 indexed citations
17.
Prescott, Benjamin, et al.. (1969). 4-(1-adamantyl)-3-thiosemicarbazones as potential chemotherapeutic agents.. PubMed. 9. 275–9. 1 indexed citations
18.
Prescott, Benjamin, G. Caldes, William D. James, & Robert M. Chanock. (1967). PHOSPHOLIPID HAPTEN OF MYCOPLASMA PNEUMONIAE. Annals of the New York Academy of Sciences. 143(1). 497–500. 8 indexed citations
19.
Prescott, Benjamin, G. Kauffmann, & William D. James. (1958). Means of increasing the tolerated dose of isoniazid in mice. IV. Certain keto acids.. PubMed. 8(7). 349–53. 3 indexed citations
20.
Prescott, Benjamin, Gladys Kauffmann, & William D. James. (1957). Increase in Tolerated Dose of Isoniazid in Mice by Use of Cycloserine. Experimental Biology and Medicine. 94(1). 94–96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026